about
Heart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?Anthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer PatientsStem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.Radiotherapy and anthracyclines - cardiovascular toxicityThe impact of radiotherapy costs on clinical outcomes in breast cancerThe Early Predictive Value of Right Ventricular Strain in Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer.Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.Inflammation and Cancer: In Medio Stat Nano.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Troponin through the looking-glass: emerging roles beyond regulation of striated muscle contraction.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.Causal Phenotyping for Susceptibility to Cardiotoxicity from Antineoplastic Breast Cancer Medications.Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
P2860
Q26740352-6B2DA870-FE76-4199-AE7D-DFB9080D993FQ33658456-C0B4E27D-3076-439C-9CE5-3A95B1129BA2Q33816471-BD5B3202-5E13-4753-995F-DD3BF76961C0Q34441749-8D095511-8E43-4664-A23B-CD9542994D08Q35648956-E3003A53-642D-4EC1-8057-900587AA5EDCQ36592346-43C41C5E-F05A-4DB0-A8D3-9DB53752E54CQ37314505-3DB55D53-00D5-430C-BA4A-E26DFBBA556FQ42204826-A1B0F180-DD6A-40DB-8FA9-44B5F66477C2Q47877048-BBB55239-CF69-4F1C-835D-1E25FEC2CDADQ49315568-2E0BB1FF-2781-4BDD-B3B8-F0C5E13B4973Q49376239-DAE7951A-BDBC-42B7-8C6A-5AB1A5AA4A83Q54959206-B5F269C6-A3FB-49A6-9245-7160D27FCD24Q55194501-12FF351E-F2A6-4861-95AC-40ED82A13B17Q55262271-A1B1675E-A6B0-482B-AFD3-2139C3041853
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Chemotherapy-induced Cardiotoxicity.
@en
Chemotherapy-induced Cardiotoxicity.
@nl
type
label
Chemotherapy-induced Cardiotoxicity.
@en
Chemotherapy-induced Cardiotoxicity.
@nl
prefLabel
Chemotherapy-induced Cardiotoxicity.
@en
Chemotherapy-induced Cardiotoxicity.
@nl
P2093
P2860
P1433
P1476
Chemotherapy-induced Cardiotoxicity
@en
P2093
Dragos Vinereanu
Maria Florescu
Mircea Cinteza
P2860
P577
2013-03-01T00:00:00Z